The migration of neutrophiles from intravascular spaces to sites of inflammation or tissue injury is initiated by their rolling on the activated vascular endothelium.
, 1), albeit with different affinities. Therefore, controlled blocking of the SLe X -selectin binding by SLe X analogs is a promising new therapeutic approach to battling inflammatory diseases. 3) SLe X or its analogs may also be useful as effective homing devices for active-targeting DDS (drug delivery system) to inflammatory lesions, since E-selectin is only expressed on such lesions. In connection with our work on developing DDS, we have found some polysaccharides with molecular sizes above 70 kDa such as carboxymethylchitosan (CMCht), and carboxymethylpullulan (CMPul) to be useful as carriers.
4) Recently, we reported a SLe X -CMPul conjugate to be a good carrier in active-targeting DDS to inflammatory lesions.
5) To our knowledge, this was the first experimental result to give evidence of SLe X being useful as a DDS homing device. In the case of SLe X -selectin interaction, the structure-function relationship study and conformational analysis have led to the rational development of SLe X mimetics which may be comparable to or even better than the natural ligand as inhibitors of selectins. Several groups have been actively engaged in this effort, and several SLe X mimetics have been reported. 6) However, considering the complicated synthesis of SLe X and cost factors, there is still a need for the development of simplified SLe X mimetics which are more synthetically accessible and yet retain their usefulness as a homing device.
In trying to design novel SLe X mimetics, we have focused our attention on the space distance and orientation between the negative charge of sialic acid and the three hydroxyl groups of the fucose residue. Several workers have reported that both sialic acid carboxylate and fucose hydroxyl groups were essential for the binding of SLe X to selectin while the N-acetyl glucosamine moiety tolerated some variation. Therefore, by introducing our mimic to the DDS carrier, we designed biantennary glycoside-terminated ligands (2, 3) that replaced the N-acetyl glucosamine moiety of SLe X with a Boc-L-glutamic acid linked adequate spacer arm (C6 carbon chain, and triethylene glycol) as illustrated in Fig. 1 . Thus, using the amino group of L-glutamic acid, our mimic could be easily introduced to liposome 8) or polysaccharides, 4) which are useful as DDS carriers.
Here we describe the synthesis and evalution of these SLe X mimicking compounds.
Synthesis and in Vitro Assay
The synthesis of 2 is presented in Chart 1. 1-O-p-Nitrobenzoyl-2,3,4-tri-O-benzyl-Lfucopyranose (10, a : bϭ36 : 64) 9) was reacted with 6-azidohexanol 10) in the presence of zinc trifluoromethanesulfonate (Zn(OTf) 2 )/chlorotrimethylsilane (TMSCl) 11) to give a-glycoside (11) in 72% yield and b-glycoside (27%). Selective reduction (Lindlar's cat./H 2 /p-toluenesulfonic acid monohydrate (p-TsOH · H 2 O)) of the azido group of 11 led to an amine, which was condensed with BocGlu(OBn) followed by selective hydrogenation of benzyl ester, 12) to furnish the fucose-glutamic acid moiety (14) .
On the other hand, the sialyl-galactose azide (18) was prepared from imidate (17) 13) by treatment with azidohexanol in the presence of BF 3 · OEt 2 .
Reduction of the azido group of 18 followed by coupling with the fucose-glutamic acid moiety (14) , afforded 20 [1) Lindlar's cat./H 2 /p-TsOH · H 2 O 2) 1,3-dicyclohexylcarbodiimide (DCC)/N-hydroxysuccinimide (HOSu), 47%], which was deprotected in three steps. [1) NaOMe-MeOH 2) aq.NaOH 3) Pd-C/H 2 /MeOH, 85%].
Compound 3, which had triethylene glycol as a spacer instead of the C6 carbon chain in 2, was synthesized by the same procedure as 2.
The binding activity to E-selectin of 1, 2 and 3 was evaluated using HL-60 cells expressing SLe X epitope and HUVEC (Human Umbilical Vein Endothelial Cells) (details are given in the Experimental section). Compound 2 was found to possess a potent inhibitory activity to E-selectin (IC 50 values: 1, 1.0 mM; 2, 11.7 mM), whereas compound 3 was completely inactive. The lipophilicity of the spacer is apparently neccessary for the spatial arrangement of the essential sialic acid carboxylate and fucose hydroxyl groups. Next, we synthesized various biantennary ligands with fucose and other sugar derivative residues (4-8) that simplified the sialylgalactose moieties of 2 (Fig.2) .
For the synthesis of 4, coupling of thioglycoside (22) 14) and azidohexanol using N-iodosuccinimide (NIS) and trifluoromethanesulfonic acid (TfOH) as the promoter 15) in CH 3 CN gave a-glycoside (23) in 51% yield along with b-glycoside (24, 24%), which was converted to 4 according to a procedure similar to that described for 2 (Chart 2).
For the synthesis of sulfated analog (5), treatment of 1,2,3,4,6-penta-O-acetyl-a-D-galactopyranosyl bromide with azidohexanol in the presence of silver silicate 16) in CH 2 Cl 2 followed by deacetylation gave b-glycoside (26) in 75% yield, which was converted to 2,4,6-tri-O-benzyl 3-O-pmethoxybenzyl galactose derivative (28) via selective alkylation at the O-3 position in b-galactoside derivative using dibutyltin oxide/tetrabutylammonium bromide (62%).
Reduction of the azido group of 28 followed by condensation with the fucose-glutamic acid moiety (14) gave 32. The p-methoxybenzyl group was removed oxidatively from 32 using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (72%), and the sulfate group was attached in its place (SO 3 · NMe 2 /N,NЈ-dimethylformamide (DMF), 63%) to furnish 34. Finally, debenzylation of 34 (Pd-C/H 2 /MeOH, 82%) gave the sulfated analog (5).
For the synthesis of 6, 26 was converted to 30 via selective allylation at the O-3 position in the b-galactoside derivative using dibutyltin oxide/tetrabutylammonium bromide. Ozonolysis of 30 followed by reductive work up, oxidation of the formyl group and methylation with trimethylsilyldiazomethane (TMSCHN 2 ) gave 31 (60%), which was converted to 6 according to a procedure similar to that described for 2.
Compound 7, which has no acidic functional group, was easily prepared from 32 by hydrogenolysis.
For the synthesis of 8, reduction of the azido group of 11 followed by condensation with Boc-L-Glu, gave the hexabenzyl ether derivative (36), which was then reduced to 8 using Pd-C/H 2 (Chart 4).
The biological activity of 4-8 was tested with the binding assay using HL-60 cells and HUVEC. These compounds except 7 were found to have moderate binding activities to Eselectin (IC 50 value: 4, 7.4 mM; 5, 11.4 mM; 6, 12.8 mM; 8, 4.7 mM). Interestingly, compound 8 having no sialic acid carboxylate, was the most active among these analogs. The two fucose residues, not sialic acid carboxylate, were essential for the binding to E-selectin. The difucose analog (9) which has the more hydrophilic triethylene glycol arms as a spacer was found to be inactive like 3 (Chart 4). The spatial arrangement of the two fucose residues was important and the conformation for the desired interaction was dependent on the length and lipophilicity of the spacer arms.
In Vivo Assay The in vivo effect of compound 8 was examined on the rat pleuritic model induced by carrageenin. 17) As controls, SLe X (1) and 9 were also examined. Each compound was administered intravenously at 0, 2 and 4 h after carrageenin challenge (dose: 5 mg/kgϫ3 times). After 24 h, the number of neutrophils and the amount of exudate proteins were measured.
As shown in Fig. 3 , 8 reduced neutrophil infiltration at the inflammatory lesion, while 9, which had no binding activity at the in vitro assay, was inactive. Thus, the results of the in vivo assay almost paralleled to those of the in vitro assay. Compound 8 was shown to reach the inflammatory lesion in vivo and offer the possibility of being a useful homing device aimed at inflammatory lesions.
On the other hand, 8 was almost inactive for reducing exudate proteins, similar to 9. These results showed that 8 did not affect the vascular permeability, namely, no anti-inflammatory effect of 8 was observed at this dose.
In conclusion, we demonstrated the practical synthesis of biantennary oligosaccharide ligands mimicking SLe X . These ligands have moderate binding activitites to E-selectin. Compound 8 was found to reduce neutrophil infiltration at inflammatory lesions in vivo. The spatial arrangement of the two fucose residues, and the length and lipophilicity of the spacer were important for binding to E-selectin. These ligands should be useful as effective homing devices for active targeting DDS of inflammatory lesions. As cell-surface receptor-ligand interactions are often multivalent, inhibitors prepared in multivalent form should increase the inhibition potency.
18) As for application to DDS, Boc groups of 8, 25, 36 could be easily deprotected without cleavage of the glycosidic bond (trifluoroacetic acid (TFA)/0°C). Utilizing the amino groups, we are presently trying to introduce these branched oligosaccharides to CMPul (M.W. 150 kDa). 
Experimental
All melting points were determined on a Yanagimoto micromelting point apparatus and were not corrected.
1 H-NMR spectra were measured on a Varian VXR-500S (500 MHz) spectrometer, unless otherwise specified. H-NMR (300 MHz) and 13 C-NMR (75 MHz) were measured on a Varian VXR-300S. Chemical shifts (d) are given in ppm relative to tetramethylsilane as an internal standard. IR spectra were measured on a Shimadzu FT-IR-4300. Optical rotations were determined with a Perkin-Elmer 430 polarimeter. FAB-Mass spectra were recorded on a Hitachi M-90 instrument.
6-Azidohexyl 2,3,4-tri-O-Benzyl-a a-L-fucopyranoside (11) To a stirred solution of 1-O-p-nitrobenzoyl 2,3,4-tri-O-benzyl-L-fucopyranose 8) (10, a : b ϭ36 : 64, 100 mg, 0.171 mmol), 6-azidohexanol 9) (37 mg, 0.257 mmol), and Zn(OTf) 2 (94 mg, 0.257 mmol) in acetonitrile (2.0 ml) at 0°C was added TMSCl (33 ml, 0.257 mmol). After being stirred at 0°C for 1 h, the mixture was diluted with ethyl acetate, washed with brine and saturated aqueous NaHCO 3 , dried over MgSO 4 and concentrated in vacuo. The crude product was purified by preparative TLC [hexane/ethyl acetate (6/1, v/v)] to give 11 (60 mg, 64%), and b-glycoside (21 mg, 22% 76.4, 77.7, 79.2, 127.3, 127.4, 127.8, 128.06, 128.16, 128.22, 138.5, 138.7, 138.9. Anal. Calcd for C 33 H 41 N 3 O 5 : C, 70.82; H, 7.38; N, 7.51. Found: C, 71, 05; H, 7.38; N, 7.23 3 O 5 : C, 70.82; H, 7.38; N, 7.51. Found: C, 71, 01; H, 7.30; N, 7.41 . 76.4, 77.7, 79.3, 79.9 (-NHCO 2 C(CH 3 )), 97.4 (C-1 of Fuc), 127. 3, 127.5, 127.8, 128.07, 128.14, 128.18, 128.21, 128.25, 128.3, 128.5, 135.6, 138.5, 138.7, 138.9, , 7.56; N, 3.28. Found: C, 70.35; H, 7.50 ; N, 3.46 .
To a solution of 13 (360 mg, 0.422 mmol) in ethanol (5 ml) was added 10%Pd-C (360 mg) and 1,4-cyclohexadiene (650 ml, 6.87 mmol). 12) After being stirred for 1 h at room temperature, the catalyst was filtered off. The filtrates were concentrated in vacuo to give 14 (282 mg, 88%) as colorless powder. m), 3.41 (1H, ddd, Jϭ9.9, 6.6, 6 .6 Hz), 3.57 (1H, ddd, Jϭ9.9, 7.1, 7 .1 Hz), 3.67 (1H, br d, H-4 of Fuc), 3.86 (1H, q, Jϭ6.6 Hz, H-5 of Fuc), 3.93 (1H, dd, Jϭ10.3, 3.0 Hz, 4.02 (1H, dd, Jϭ10.3, 3. 
6-Azidohexyl O-(Methyl 5-Acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a a -D-galacto-2-nonulopyranosylonate)-(2→
To a solution of 6-azidohexanol 10) (131 mg, 0.912 mmol) and 17 13) (300 mg, 0.304 mmol) in dichloromethane (10 ml), was added activated molecular sieves 4A (MS4A, 4 g). The mixture was stirred at room temperature for 2 h and then cooled to 0°C. To the solution was added BF 3 · OEt 2 (112 ml, 0.912 mmol), and the stirring was continued at 0°C for 1 h. The reaction mixture was diluted with dichloromethane, and filtered though a Celite bed. The filtrates were washed with saturated aqueous NaHCO 3 , dried over MgSO 4 and concentrated in vacuo. The crude product was purified by silica gel column chromatography (SiO 2 20 g, dichloromethane : methanolϭ50 : 1, v/v) 1.72 (1H, dd, Jϭ12.7, 12.3 Hz, H-3 of Sia), 1.85, 2.00, 2.04, 2.08, 2.13, 2.21 (each 3H, s), 2.59 (1H, dd, Jϭ12.7, 4.6 Hz, H-3 of Sia), 3.25 (2H, t, Jϭ7.0 Hz), 3.54 (1H, dt, Jϭ9.5, 6 .6 Hz), 3.63 (1H, dd, Jϭ10.7, 2.4 Hz, H-6 of Sia), 3.76 (3H, s), 3.88 (1H, dt, Jϭ9.5, 6.3 Hz), 3.99 (1H, dd, Jϭ7.1, 6.3 
To a stirred solution of 18 (130 mg, 0.136 mmol) in methanol (10 ml) was added p-TsOH · H 2 O (26 mg, 0.136 mmol), and the mixture was hydrogenated over Lindlar's catalyst (100 mg) at 3.5ϫ10 4 kg/m 2 (50 psi) for 2 h. The catalyst was filtered off and the solvent was removed in vacuo, giving 6-aminohexyl O- (methyl 5-acetamido-4,7,8,9- 
To a solution of 14 (125 mg) in dichloromethane (1.5 ml) were added HOSu (17.5 mg, 0.152 mmol), and DCC (31.0 mg, 0.150 mmol). After being stirred at 0°C for 3 h, 6-aminohexyl O-(methyl 5-acetamido-4,7,8,9- 
, and triethylamine (25 ml, 0.179 mmol) were added, and the stirring was continued at 0°C for 12 h. After the precipitates were filtered off, the filtrates were diluted with dichloromethane, washed with saturated aqueous NaHCO 3 , dried over MgSO 4 and concentrated in vacuo. The crude product was purified by silica gel column chromatography (SiO 2 20 g, toluene : acetoneϭ7 : 4, v/v) to give 20 (93 mg, 41%) as a colorless powder.
[ : C, 61.27; H, 6.94; N, 3.32. Found: C, 61.01; H, 7.01; N, 3.13 .
To a solution of 20 (118 mg, 0.070 mmol) in methanol (2 ml) at 0°C was added 3% sodium methoxide in methanol (400 ml), and stirring was continued at 0°C for 2 h. The mixture was neutralized with Dowex 50W-X8 (hydrogen form), filtered, and concentrated in vacuo.
The residue was dissolved in 1,4-dioxane, and then to the solution was added 0.1 N sodium hydroxide (2.0 ml). After being stirred at room temperature for 1 h, the mixture was neutralized with Dowex 50W-X8 (hydrogen form), filtered, and concentrated in vacuo. Column chromatography of the residue on Sephadex methanol) gave To a solution of C, 67.85; H, 7.29; N, 3.19. Found: C, 67.98; H, 7.31; N, 3.19 . 13; H, 6.75; N, 3.15. Found: C, 58.13; H, 6.62 ; N, 3.19 . 
Methyl (6-Azidohexyl 5-Acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-O-D-glycero-a a-D-galacto-2-nonulopyranosid)onate (23) and Methyl (6-azidohexyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-O-D-glycerob b-D-galacto-2-nonulopyranosid)onate (24)
To a solution of 6-azidohexanol 10) (344 mg, 2.40 mmol) and 22 14) (609 mg, 1.20 mmol), was added activated molecular sieves 3A (MS3A, 1.5 g). The mixture was stirred at room temperature for 2 h and then cooled to Ϫ40°C. To the solution were added NIS (542 mg, 2.40 mmol), and TfOH (22 ml, 0.240 mmol), and the stirring was continued at Ϫ40°C for 1 h. The reaction mixture was diluted with dichloromethane, and then filtered. The filtrates were washed with saturated aqueous Na 2 S 2 O 5 , and saturated aqueous NaHCO 3 , successively, dried over MgSO 4 and concentrated in vacuo.
The crude product was purified by silica gel column chromatography (SiO 2 200 g, dichloromethane : methanolϭ75 : 1, v/v) to give 23 (370 mg, 51%) and 24 (170 mg, 24% , 7.42; N, 4.17. Found: C, 61.63; H, 7.41; N, 4.24 . 73 mmol) and 6-azidohexanol 10) (2.08 g, 14.5 mmol) was added activated MS4A (4 g). The mixture was stirred at room temperature for 2 h, and then cooled to Ϫ20°C. To the solution was added silver-silicate 16) (10 g), and the stirring was continued at 0°C for 2 h. The reaction mixture was diluted with dichloromethane, and filtered though a Celite bed. The mixture was washed with H 2 O, dried over MgSO 4 and concentrated in vacuo.
-tert-Butyloxycarbonyl-N 5 -[6-O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a a-D-galacto-2-nonulopyranosylonate)-oxyhexyl]-N 1 -[6-(2,3,4-tri-O-benzyl-a a-L-fucopyranosyloxy)hexyl]-L-glutamin-a a-amide (25)
To a solution of the residue in methanol (20 ml) was added 28% sodium methoxide in methanol (500 ml), and the stirring was continued at room temperature for 10 min. The mixture was neutralized with Dowex 50W-X8 (hydrogen form), filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography (SiO 2 200 g, dichloromethane : methanolϭ15 : 2, v/v) to give 26 (1.83 3.45 (1H, dd, Jϭ10.0, 3.4 Hz), m), 3.55 (1H, dt, Jϭ9.5, 6.8 Hz), 3.72 (1H, dd, Jϭ11.2, 5.6 Hz, H-6 of Gal), 3.75 (1H, dd, Jϭ11.2, 6.6 Hz, H-6 of Gal), 3.82 (1H, m), 3.90 (1H, dt, Jϭ9.5, 6.8 Hz), 4.10 (1H, d, Jϭ7.6 Hz, H-1 of Gal).
6-Azidohexyl 2,4,6-tri-O-acetyl-3-O-p-methoxybenzyl-b b-D-galactopyranoside (27)
To a solution of 26 (3.26 g, 10.7 mmol) in methanol (50 ml) was added dibutyltin oxide (2.93 g, 11.8 mmol). After being stirred at reflux for 2 h, the solvent was removed by evaporation.
To a solution of the residue in benzene (50 ml) were added p-methoxybenzylchloride (MPMCl, 4.35 ml, 32.1 mmol) and tetra-butylammonium bromide (3.45 g, 10.7 mmol) , and the stirring was continued at reflux for 2 h. The mixture was cooled to room temperature, and concentrated to give the crude alcohol, which was acetylated with acetic anhydride (12 ml) and pyridine (20 ml) at room temperature for 12 h. After usual aqueous work-up, the crude product was purified by silica gel column chromatography (SiO 2 450 g, hexane : ethyl acetateϭ3 : 1, v/v) to give 27 (3.66 g, 62%) as a colorless syrup.
[ 3.43 (1H, dt, Jϭ9.5, 7.1 Hz), 3.50 (1H, dd, Jϭ10.0, 3.4 Hz, H-3 of Gal), 3.78 (1H, t-like, H-5 of Gal), 3.81 (3H, s), 3.86 (1H, dt, Jϭ9.8, 6.3 Hz), 4.15 (1H, dd, Jϭ12.9, 6.6 Hz, H-6 of Gal), 4.18 (1H, dd, Jϭ12.9, 6.6 O: C, 55.71; H, 6.83; N, 7.50. Found: C, 55.82 H, 6.67; N, 7.40 .
6-Azidohexyl 2,4,6-tri-O-benzyl-3-O-p-methoxybenzyl-b b-D-galactopyranoside (28)
To a solution of 27 (2.60 g, 4.71 mmol) in methanol (30 ml) was added 28% sodium methoxide in methanol (300 ml), and the stirring was continued at room temperature for 2 h. The mixture was neutralized with Dowex 50W-X8 (hydrogen form), filtered, and concentrated in vacuo.
To a solution of the residue in DMF (30 ml) was added sodium hydride (60%, 1.13 g, 28.3 mmol) at 0°C. After being stirred at 0°C for 30 min, benzylbromide (2.24 ml, 18.8 mmol) was added, and then the stirring was continued at room temperature for 20 h. To this mixture were added methanol (10 ml) and 28% sodium methoxide in methanol (7 ml), and the mixture was stirred at room temperature for 30 min. The mixture was poured into brine, and extracted with ethyl acetate. The extracts were dried over MgSO 4 and concentrated in vacuo.
The crude product was purified by silica gel column chromatography (SiO 2 150 g, hexane : ethyl acetateϭ3 : 1, v/v) to give 28 (2.67 g, 82%) as a colorless syrup.
[a] D 23 Ϫ6.5°(cϭ1.02, CHCl 3 ). IR (CHCl 3 ) cm Ϫ1 : 2100. (3H, m) , 3.14-3.27 (4H, m), 3.41 (1H, dt, Jϭ9.8, 6 .6 Hz), 3.48 (1H, dt, Jϭ9.5, 6.8 Hz), 3.55 (1H, dd, Jϭ9.8, 7.6 Hz, H-2 of Gal), 3.57 (1H, dt, Jϭ9.8, 7.1 Hz), m), 3.66 (1H, br d), m), 3.92 (1H, q, Jϭ6.3 Hz, H-5 of Fuc), 3.93 (1H, dd, Jϭ10.3, 2.9 Hz, 4.02 (1H, dd, Jϭ10.3, 3. 12; H, 7.71; N, 3.18. Found: C, 69.09; H, 7.60; N, 3.33 . mmol), and the stirring was continued at 55°C for 30 min. The mixture was concentrated, and then to the residue were added methanol (5 ml) and Dowex 50W-X8 (sodium form). After being stirred at room temperature for 30 min, the mixture was filtered, then the filtrates were concentrated in vacuo. The crude product was purified by silica gel column chromatography (SiO 2 45 g, toluene : acetone : methanolϭ600 : 100 : 7, v/v), and gel filtration (Sephadex LH20, 100 g, methanol to give 34 (265 mg, 63%) as a colorless powder.
1 H-NMR (CD 3 OD) d: 1.13 (3H, d, Jϭ6.6 Hz, H-6 of Fuc), 1.25-1.53 (12H, m), 1.42 (9H, s), 1.54-1.64 (4H, m), 1.82 (1H, m), 1.99 (1H, m) , 2.18-2.29 (3H, m), 3.07-3.23 (4H, m) , 3.39 (1H, dt, Jϭ10.0, 6.3 Hz), 3.42 (1H, dd, Jϭ9.8, 6 .1 Hz, H-6 of Gal), 3.51 (1H, dd, Jϭ9.8, 6.3 Hz, H-6 of Gal), 3.51 (1H, m), 3.61 (1H, m) , 3.62 (1H, dd, Jϭ9.5, 7.6 Hz, H-2 of Gal), 3.68 (1H, dd, Jϭ6.3, 6.1 Hz, 3.79 (1H, br s), 3.84 (1H, Jϭ9.8, 6.1 Hz), 3.90 (1H, q, Jϭ6.6 Hz, m) m), 5.03 (1H, d, Jϭ11.5 Hz), m), . m), 3.44 (1H, dt, Jϭ9.8, 6.3 Hz), 3.54 (1H, m), m), 3.69 (1H, dd, Jϭ9.3, 7.8 Hz, H-2 of Gal), m), 3.90 (1H, dt, Jϭ9.5, 6.8 Hz), 3.94 (1H, q, Jϭ6. C, 46.25; H, 7.42; N, 4.76. Found: C, 46.11; H, 7.27; N, 4.78. 6-(tert-Butyloxycarbonylamino)-hexyl 2,3,4,6-tetra-O-acetyl-b b-D-galactopyranoside (29) To a stirred solution of 26 (2.18 g, 7.14 mmol) in methanol (80 ml) was added p-TsOH · H 2 O (1.36 g, 7.15 mmol) , and the mixture was hydrogenated over Lindlar's catalyst (3.00 g) at 3.5ϫ10 4 kg/m 2 (50 psi) for 4 h. The catalyst was filtered off and the solvent was removed in vacuo, giving 6-aminohexyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside ptoluenesulfonate (2.93 g) as a viscous pale brown oil.
To a solution of 6-aminohexyl 2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside p-toluenesulfonate (2.93 g) in methanol (20 ml) were added triethylamine (1 ml) and Boc 2 O (2.03 g, 9.30 mmol). After being stirred at room temperature for 12 h, the mixture was concentrated to give the crude alcohol, which was acetylated with acetic anhydride (15 ml) and pyridine (25 ml) at room temperature for 12 h. After usual aqueous work-up, the crude product was purified by silica gel column chromatography (SiO 2 150 g, hexane : ethyl acetateϭ2 : 1, v/v) m), 3.47 (1H, dt, Jϭ9.5, 6.8 Hz), 3.89 (1H, m), 3.90 (1H, dd, Jϭ7.1, 6.3 Hz, 4.13 (1H, dd, Jϭ11.2, 7.1 Hz, 4.19 (1H, dd, Jϭ11.2, 6.3 Hz, 4.45 (1H, d, Jϭ8.1 Hz, 4.53 (1H, br s, NH), 5.02 (1H, dd, Jϭ10.5, 3.4 Hz, 5.20 (1H, dd, Jϭ10.5, 8.1 Hz, 5.39 (1H, br d, Jϭ3.2 Hz, . Anal. Calcd for C 25 H 41 NO 12 : C, 54.84; H, 7.55; N, 2.56. Found: C, 54.58; H, 7.54; N, 2.56 . (1.68 g, 3. 07 mmol) in methanol (30 ml) was added 28% sodium methoxide in methanol (500 ml), and the stirring was continued at room temperature for 10 min. The mixture was neutralized with Dowex 50W-X8 (hydrogen form), filtered, and concentrated in vacuo.
To a solution of the residue in methanol (20 ml) was added dibutyltin oxide (844 mg, 3.39 mmol). After being stirred at reflux for 2 h, the solvent was removed by evaporation.
To a solution of the residue in benzene (20 ml) were added allylbromide (0.80 ml, 9.24 mmol) and tetra-butylammonium bromide (990 mg, 3.07 mmol), and the stirring was continued at reflux for 2 h. The reaction mixture was cooled to room temperature, and concentrated to give the crude alcohol, which was acetylated with acetic anhydride (6 ml) and pyridine (10 ml) at room temperature for 12 h. After the usual aqueous work-up, the crude product was purified by silica gel column chromatography (SiO 2 120 g, hexane : ethyl acetateϭ2 : 1, v/v) m), 3.45 (1H, dt, Jϭ9.5, 6.8 Hz), 3.51 (1H, dd, Jϭ10.0, 3.4 Hz, H-3 of Gal), 3.80 (1H, dd, Jϭ6.6, 6 .6, 1.0 Hz, H-5 of Gal), 3.87 (1H, dt, Jϭ9.5, 6.4 6-(tert-Butyloxycarbonylamino)-hexyl 2,4,6-tri-O-acetyl-3-O-methoxy carbonylmethyl-b b-D-galactopyranoside (31) A solution of 30 (645 mg, 1.18 mmol) in methanol (45 ml) was cooled to Ϫ78°C. Ozone was passed though the solution until a faint blue color appeared, and then oxygen was passed in until the solution became colorless. Dimethylsulfide (5 ml) was added to the mixture, and the mixture was stirred for 1 h at room temperature. After removal of the solvent in vacuo, the residue was chomatographed on a silica gel column (SiO 2 45 g, hexane : ethyl acetate : methanolϭ200 : 300 : 5, v/v) to give a crude aldehyde (577 mg).
To a solution of the crude aldehyde (577 mg) in 2-methyl 2-propanol (20 ml) and 2-methyl-2-butene (5 ml) was added a solution of NaClO 2 (2.67 g, 29.5 mmol) and NaH 2 PO 4 · 2H 2 O (3.68 g, 23.6 mmol) in H 2 O (10 ml), and the stirring was continued at room temperature for 4 h. The mixture was diluted with ethyl acetate, washed with H 2 O, dried over MgSO 4 and concentrated in vacuo to give the crude carboxylic acid, which was methylated with TMSCHN 2 in methanol-hexane at room temperaturure for 1 h. After the usual work-up, the crude product was purified by silica gel column chromatography (SiO 2 120 g, hexane : ethyl acetate : methanolϭ300 13 : C, 54.06; H, 7.50; N, 2.42. Found: C, 53.79; H, 7.44; N, 2.44 . (1H, m) , 2.06, 2.14, 2.14 (each 3H, s), 2.27 (1H, m), 2.35 (1H, m), m), 3.42 (1H, dt, Jϭ9.8, 6 .6 Hz), 3.45 (1H, dt, Jϭ9.5, 6 .6 Hz), 3.57 (1H, dt, Jϭ9.8, 7.1 Hz), 3.66 (1H, dd, Jϭ9.8, 3.4 Hz, H-3 of Gal), 3.67 (1H, br s, H-4 of Fuc), 3.72 (3H, s), 3.78 (1H, dd, Jϭ6.6, 6.6 Hz, H-5 of Gal), 3.86 (1H, q, Jϭ6.6 Hz, H-5 of Fuc), 3.88 (1H, m), 3.93 (1H, dd, Jϭ10.0, 3.4 Hz, 4.02 (1H, dd, Jϭ10.0, 3. 41-7.24 (15H, m) . m), 3.26 (1H, m), 3.53 (1H, m), 3.53 (1H, dd, Jϭ10.0, 3.2 Hz, H-3 of Gal), 3.66 (1H, dd, Jϭ10.0, 7.8 Hz, H-2 of Gal), m), m), 3.86 (1H, dd, Jϭ10.3, 3. : C, 53.26; H, 8.07; N, 5.18. Found: C, 53.19; H, 8.27; N, 5.08 . (2H, m) , m), 3.44 (1H, m), 3.45 (1H, dd, Jϭ9.8, 3 .2 Hz), 3.47-3.59 (2H, m, H-2,5 of Gal), 3.54 (1H, ddd, Jϭ9.5, 6.6, 6.6 Hz), m), 3.83 (1H, br d, m), 3.90 (1H, ddd, Jϭ9.5, 6.8, 6 .8 Hz), 3.93 (1H, q, Jϭ6. : C, 54.17; H, 8.64; N, 5.60. Found: C, 54.11; H, 8.71; N, 5.71 . , and DCC (136 mg, 0.660 mmol). After being stirred at 0°C for 3 h, 6-aminohexyl 2,3,4-tri-O-benzyl-a-L-fucopyranoside p-toluenesulfonate (466 mg, 0.66 mmol), and triethylamine (134 ml, 0.66 mmol) were added, and the stirring was continued at 0°C for 12 h. After the precipitates were filtered off, the filtrates were diluted with dichloromethane, washed with saturated aqueous NaHCO 3 , dried over MgSO 4 and concentrated in vacuo. The crude product was purified by silica gel column chromatography (SiO 2 60 g, chloroform : methanolϭ100 : 1, v/v) : C, 71.39; H, 7.80; N, 3.29. Found: C, 71.21; H, 7.89; N, 3.49 . 9, 27.6, 27.7, 28.7, 29.5, 30.3, 30.5, 33.3, 40 .2 (-CH 2 NHCO), 40.4 (-CH 2 NHCO), 55.7, 67.4, 69.1, 70.0, 71.7, 73.6, 80 .6 (-NHCO 2 C(CH 3 ) 3 ), 100.4 (C-1 of Fuc), 157.7 (-NHCO 2 C(CH 3 ) 3 ), 174.5, 174.8. Anal. Calcd for C 34 H 63 N 3 O 14 · H 2 O: C, 54.03; H, 8.67; N, 5.56. Found: C, 54.30; H, 8.64; N, 5.60 . 4.64, 4.78, 4.78, 4.85, 4.86, 4.97 (each 2H, d, Jϭ11.4 Hz, -CH 2 Ph), 5.63 (1H, d, Jϭ7.2 Hz), 6.72 (1H, t-like), 7.10 (1H, br s), 7. 24-7.42 (30H, m) . N 1 , N 5 -bis-(8-a a-L-fucopyranosyloxy-3,6-dioxaoctyl)-N 2 -tert-butyloxycarbonyl-L-glutamin-a a-amide (9) Following the procedure described for 5, 37 was converted to 9 (95% 
